Security key
83422E204
Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB)
CUSIP: 83422E204
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 78,846,500
- Total 13F value
- $291,701,746
- Share change
- +42,692,186
- Put/Call ratio
- 117%
- SEC-reported price per share
- $3.70
- Number of holders
- 121
- Value change
- +$157,692,840
- Number of buys
- 90
- Number of sells
- 28
- Shares outstanding
- 100,704,083
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
121
Top holders
10
SLDB full security history
Ownership snapshot
Full 13F holder table
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
Bain Capital Life Science...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 9.6%
13D/G row: Invus Global Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Invus Global Management, LLC leads the comparable SEC ownership view at 9.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership
Top 5
Invus Global Management, LLC
9.6%
PERCEPTIVE ADVISORS LLC
6.9%
RA CAPITAL MANAGEMENT, L.P.
4.3%
Bain Capital Life Sciences Invest...
4%
Siren, L.L.C.
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
9.6%
|
$27,216,371
7,415,905 shares
|
+$13,457,391 | 31 Mar 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
6.9%
|
$27,626,584
6,906,646 shares
|
— | 31 Dec 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4.3%
|
$17,321,784
4,330,446 shares
|
— | 31 Dec 2024 |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
13F
10%+ Owner · Company
|
4%
from 13F
|
$46,252,926
11,478,752 shares
mixed-class rows
|
— | 19 Feb 2025 |
| Siren, L.L.C. |
13F
Individual
|
3.7%
|
$14,996,164
3,749,041 shares
|
— | 31 Dec 2024 |
| Vestal Point Capital, LP |
13F
Company
|
2.8%
|
$11,400,000
2,850,000 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
121
Shares
78,846,500
Rows available
121
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
121
Q1 2025 holders
121
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|